Activity of transplanted CD8+ versus CD4+ cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice.
Rencher
S D
SD
Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.
Slobod
K S
KS
Smith
F S
FS
Hurwitz
J L
JL
D000818:Animals; D001402:B-Lymphocytes / Q000382:microbiology / Q000473:pathology; D002051:Burkitt Lymphoma / Q000382:microbiology / Q000517:prevention & control* / Q000628:therapy; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D016827:CD8 Antigens / Q000276:immunology*; D002472:Cell Transformation, Viral; D004195:Disease Models, Animal; D004854:Herpesvirus 4, Human; D006801:Humans; D016219:Immunotherapy, Adoptive; D016393:Lymphoma, B-Cell / Q000382:microbiology / Q000517:prevention & control* / Q000628:therapy; D051379:Mice; D016513:Mice, SCID; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000637:transplantation*; D014412:Tumor Virus Infections / Q000382:microbiology / Q000628:therapy
D016827:CD8 Antigens